GPC3 expression is often silent or decreased in ovarian cancer except clear cell carcinoma types [99], as well as in mesothelioma [66], breast cancer [72], lung adenocarcinoma [71,100], and clear cell renal carcinoma. This evidence concerns the gene GPC3 and mesothelioma.